Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00214994 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.
A Phase 3 study, sponsored by Cephalon.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00214994 is a Phase 3 study that has completed, run by Cephalon.
The verdict
NCT00214994, a Phase 3 study, has completed, sponsored by Cephalon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults with Generalized Anxiety Disorder.
Interventions
- DRUG Gabitril
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-01 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00214994
The ClinicalTrials.gov registry entry for NCT00214994 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Cephalon, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gabitril is the first listed.
NCT00214994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00214994 about?
NCT00214994 is a clinical study titled "Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.". A 12-Month, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults with Generalized Anxiety Disorder.
What is the current status of trial NCT00214994?
This trial is currently completed. It is a Phase 3 study. The study started on 2005-01. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00214994?
The interventions under investigation include: Gabitril (DRUG).
Who is sponsoring clinical trial NCT00214994?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.